Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472061 - 472080 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ02) fedratinib (adm: O) | INREBIC 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Primary Myelofibrosis | Bristol-MyersSquibbCompany |
| USA | (L01EJ02) fedratinib (adm: O) | INREBIC 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Primary Myelofibrosis | Bristol-MyersSquibbCompany |
| USA | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CTIBiopharmaCorp. |
| USA | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CTIBiopharmaCorp. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 1 MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | Pfizer,Inc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 1 MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | Pfizer,Inc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | Pfizer,Inc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | Pfizer,Inc. |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 1.34MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc.;DBAAVEOOncology |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 1.34MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc.;DBAAVEOOncology |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 0.89MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc.;DBAAVEOOncology |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 0.89MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc.;DBAAVEOOncology |
| USA | (L01EK04) fruquintinib | FRUZAQLA 1MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 1MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 5MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 5MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EL01) ibrutinib (adm: O) | IBRUTINIB 70MG/ML SUSP,ORAL | 108ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pharmacyclics,LLC |
| USA | (L01EL01) ibrutinib (adm: O) | IBRUTINIB 70MG/ML SUSP,ORAL | 108ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pharmacyclics,LLC |
Pages
